Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-12-23FDA Approved: HEPARIN SODIUM AND DEXTROSE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Heparin Sodium and Dextrose (Hospira, Inc.). The update concerns labeling/indications for this a…
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Index of Microcirculatory Resistance After Drug-Eluting Stent Implantation With High Dose Atorvastatin Loading [NA]
This clinical trial update investigates the effect of high-dose atorvastatin loading on the Index of Microcirculatory Resistance after drug-…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation
A terminated clinical trial evaluated computed tomographic coronary angiography for evaluating acute chest pain, with results posted in 2011…
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating whether genetically guided personalization of antiplatelet therapy improves outcomes in patients with st…
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice
Clinical trial update reporting the effectiveness and safety of dalteparin in patients with acute coronary syndrome without ST elevations in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome [Phase 3]
Phase 3 trial comparing different antiplatelet therapies in Asian subjects with acute coronary syndrome; results have been posted.
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: CMR in the Assessment of Patient With ACS in the Emergency Room [NA]
This clinical trial evaluating cardiac magnetic resonance imaging for assessing patients with acute coronary syndrome in the emergency depar…
-
FDA approval · 2011-09-27FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA has approved a supplemental application for EFFIENT (prasugrel hydrochloride) from Cosette Pharmaceuticals, Inc. The action represen…
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome [Phase 4]
Phase 4 trial update on atorvastatin pre-treatment in Asian patients with acute coronary syndrome; study completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Continuous Versus Interval Training in Patients With Coronary Artery Disease: FRAXIO Study [NA]
A completed study comparing continuous versus interval training in patients with acute coronary syndrome (coronary artery disease).
-
CLINICAL_TRIALS trial_result · 2011-08-17Clinical Trial Update: Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease [Phase 4]
Phase 4 clinical trial update on the efficacy and safety of the YUKON Drug Eluting Stent for diffuse coronary artery disease in patients wit…
-
CLINICAL_TRIALS research · 2011-08-12Clinical Trial Update: Ongoing WARfarin and Coronary STENTing
This document is an update on an ongoing clinical trial evaluating warfarin in conjunction with coronary stenting for patients with acute co…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: REsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary Syndromes (RECLOSE 2 - ACS)
A completed clinical trial (RECLOSE 2 - ACS) investigating how clopidogrel responsiveness relates to stent-related events in acute coronary …
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome [Phase 4]
A Phase 4 trial evaluating adapted dosing of enoxaparin in patients with acute coronary syndrome and moderate renal failure has completed.
-
FDA approval · 2011-07-20FDA Approved: BRILINTA — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved Brilinta (ticagrelor) through an original application for use in patients with acute coronary syndrome to reduce the risk of ca…
-
CLINICAL_TRIALS trial_result · 2011-07-18Clinical Trial Update: Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.
A completed clinical trial assessed the efficacy of the CMI Magnetocardiograph in diagnosing acute coronary syndromes among patients with hi…
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin
This clinical trial update investigates whether a reduced dose of enoxaparin affects outcomes in patients receiving enoxaparin therapy. The …
-
CLINICAL_TRIALS trial_result · 2011-06-16Clinical Trial Update: GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety [NA]
The GRAVITAS trial evaluated whether adjusting clopidogrel therapy based on the VerifyNow P2Y12 assay affects thrombotic outcomes and safety…
-
CLINICAL_TRIALS trial_result · 2011-06-14Clinical Trial Update: Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome [Phase 4]
Phase 4 clinical trial update evaluating intensive statin therapy in percutaneous coronary intervention patients with acute coronary syndrom…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) [Phase 4]
A Phase 4 trial evaluated fondaparinux in combination with unfractionated heparin during revascularization in acute coronary syndrome; resul…
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Vessel Wall Response of the Bio-Active-stent and Everolimus-Eluting Stent Assessed By Optical Coherence Tomography
This completed clinical trial assessed and compared the vessel wall response to a Bio-Active-stent versus an everolimus-eluting stent using …
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Comparison of Bio-Active-Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome [Phase 3]
A Phase 3 clinical trial is comparing a Bio-Active-Stent with an Everolimus-Eluting Stent in patients with Acute Coronary Syndrome; the tria…
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Coronary Flow Reserve in Patients With Bio-active Stent or Everolimus-eluting Stent Implanted in Acute Coronary Syndrome
This completed clinical trial evaluated coronary flow reserve in patients with acute coronary syndrome who received either a bio-active sten…
-
CLINICAL_TRIALS research · 2011-04-18Clinical Trial Update: Prasugrel Versus Clopidogrel in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
This trial compares prasugrel versus clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention; the…
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: A Trial of Trans-radial Versus Trans-femoral Percutaneous Coronary Intervention (PCI) Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy [Phase 3]
Phase 3 trial comparing trans-radial versus trans-femoral PCI access in patients with unstable angina or myocardial infarction managed invas…